Literature DB >> 11031271

Charged residues at the intracellular boundary of transmembrane helices 2 and 3 independently affect constitutive activity of Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor.

H H Ho1, N Ganeshalingam, A Rosenhouse-Dantsker, R Osman, M C Gershengorn.   

Abstract

Because charged residues at the intracellular ends of transmembrane helix (TMH) 2 and TMH3 of G protein-coupled receptors (GPCRs) affect signaling, we performed mutational analysis of these residues in the constitutively signaling Kaposi's sarcoma-associated herpesvirus GPCR (KSHV-GPCR). KSHV-GPCR contains the amino acid sequence Val-Arg-Tyr rather than the Asp/Glu-Arg-Tyr ((D/E)RY) motif at the intracellular end of TMH3. Mutation of Arg-143 to Ala (R143A) or Gln (R143Q) abolished constitutive signaling whereas R143K exhibited 50% of the basal activity of KSHV-GPCR. R143A was not stimulated by agonist, whereas R143Q was stimulated by growth-related oncogene-alpha, and R143K, similar to KSHV-GPCR, was stimulated further. These findings show that Arg-143 is critical for signal generation in KSHV-GPCR. In other GPCRs, Arg in this position may act as a signaling switch by movement of its sidechain from a hydrophilic pocket in the TMH bundle to a position outside the bundle. In rhodopsin, the Arg of Glu-Arg-Tyr interacts with the adjacent Asp to constrain Arg outside the TMH bundle. V142D was 70% more active than KSHV-GPCR, suggesting that an Arg residue, which is constrained outside the bundle by interacting with Asp-142, leads to a receptor that signals more actively. Because the usually conserved Asp in the middle of TMH2 is not present in KSHV-GPCR, we tested whether Asp-83 at the intracellular end of TMH2 was involved in signaling. D83N and D83A were 110 and 190% more active than KSHV-GPCR, respectively. The double mutant D83A/V142D was 510% more active than KSHV-GPCR. That is, cosubstitutions of Asp-83 by Ala and Val-142 by Asp act synergistically to increase basal signaling. A model of KSHV-GPCR predicts that Arg-143 interacts with residues in the TMH bundle and that the sidechain of Asp-83 does not interact with Arg-143. These data are consistent with the hypothesis that Arg-143 and Asp-83 independently affect the signaling activity of KSHV-GPCR.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11031271     DOI: 10.1074/jbc.M007885200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

1.  KSHV G protein-coupled receptor inhibits lytic gene transcription in primary-effusion lymphoma cells via p21-mediated inhibition of Cdk2.

Authors:  Mark Cannon; Ethel Cesarman; Chris Boshoff
Journal:  Blood       Date:  2005-09-08       Impact factor: 22.113

2.  Activation of NF-kappaB by the human herpesvirus 8 chemokine receptor ORF74: evidence for a paracrine model of Kaposi's sarcoma pathogenesis.

Authors:  S Pati; M Cavrois; H G Guo; J S Foulke; J Kim; R A Feldman; M Reitz
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

Review 3.  Molecular mechanisms deployed by virally encoded G protein-coupled receptors in human diseases.

Authors:  Silvia Montaner; Irina Kufareva; Ruben Abagyan; J Silvio Gutkind
Journal:  Annu Rev Pharmacol Toxicol       Date:  2012-10-22       Impact factor: 13.820

Review 4.  The crystallographic model of rhodopsin and its use in studies of other G protein-coupled receptors.

Authors:  Slawomir Filipek; David C Teller; Krzysztof Palczewski; Ronald Stenkamp
Journal:  Annu Rev Biophys Biomol Struct       Date:  2003-02-05

5.  Dual inhibition of PI3Kalpha and mTOR as an alternative treatment for Kaposi's sarcoma.

Authors:  Risa Chaisuparat; Jiadi Hu; Bruno C Jham; Zachary A Knight; Kevan M Shokat; Silvia Montaner
Journal:  Cancer Res       Date:  2008-10-15       Impact factor: 12.701

6.  Noncompetitive antagonism and inverse agonism as mechanism of action of nonpeptidergic antagonists at primate and rodent CXCR3 chemokine receptors.

Authors:  Dennis Verzijl; Stefania Storelli; Danny J Scholten; Leontien Bosch; Todd A Reinhart; Daniel N Streblow; Cornelis P Tensen; Carlos P Fitzsimons; Guido J R Zaman; James E Pease; Iwan J P de Esch; Martine J Smit; Rob Leurs
Journal:  J Pharmacol Exp Ther       Date:  2008-02-12       Impact factor: 4.030

Review 7.  Hijacking GPCRs by viral pathogens and tumor.

Authors:  Junjie Zhang; Hao Feng; Simin Xu; Pinghui Feng
Journal:  Biochem Pharmacol       Date:  2016-04-06       Impact factor: 5.858

8.  Galpha protein selectivity determinant specified by a viral chemokine receptor-conserved region in the C tail of the human herpesvirus 8 g protein-coupled receptor.

Authors:  Chaoqi Liu; Gordon Sandford; Guo Fei; John Nicholas
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

9.  Akt plays a central role in sarcomagenesis induced by Kaposi's sarcoma herpesvirus-encoded G protein-coupled receptor.

Authors:  Akrit Sodhi; Silvia Montaner; Vyomesh Patel; José Javier Gómez-Román; Yi Li; Edward A Sausville; Earl T Sawai; J Silvio Gutkind
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-26       Impact factor: 11.205

10.  The malignant potential of HIV-associated Kaposi sarcoma.

Authors:  Neil H Wood; Liviu Feller
Journal:  Cancer Cell Int       Date:  2008-10-31       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.